Modular Medical Announces BSI Group as Trusted Body for CE Mark Clearance
Portfolio Pulse from
Modular Medical, Inc. has engaged BSI Group to obtain CE Mark clearance for its MODD1 insulin pump, targeting Q1 2026 for European market entry.
January 30, 2025 | 1:15 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Modular Medical has partnered with BSI Group to obtain CE Mark clearance for its MODD1 insulin pump, targeting Q1 2026 for entry into the European market.
The engagement with BSI Group for CE Mark clearance is a significant step for Modular Medical's expansion into the European market. This regulatory progress is likely to positively impact investor sentiment and the stock price in the short term as it indicates growth potential and market expansion.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100